Cervical Cancer

Nov 15, 2003 Issue
The 2001 Bethesda System Terminology [Article]

The 2001 Bethesda System for reporting cervical or vaginal cytologic diagnoses is an incremental change in the uniform terminology introduced in 1988 and revised in 1991. The 2001 Bethesda System includes specific statements about specimen adequacy, general categorization, and interpretation and res...

Aug 1, 2003 Issue
Screening for Cervical Cancer [Putting Prevention into Practice]

Case study: TS, a 24-year-old, sexually active, white woman, visits your office to discuss birth control methods. She first had intercourse at age 16 and smokes two packs of cigarettes per week. You suggest that she be screened for cervical cancer as part of routine health maintenance.

May 1, 2003 Issue
ACS Updates Guidelines for the Early Detection of Cervical Neoplasia and Cancer [Practice Guidelines]

Guidelines for the early detection of cervical neoplasia and cancer are available from the American Cancer Society (ACS). The ACS recommends that cervical cancer screening begin approximately three years after the onset of vaginal intercourse or no later than 21 years of age.

Apr 15, 2003 Issue
Screening for Cervical Cancer [U.S. Preventive Services Task Force]

This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendations on screening for cervical cancer and the supporting scientific evidence.

Sep 1, 2001 Issue
New Tests for Cervical Cancer Screening [Article]

The Papanicolaou (Pap) smear has been used to screen women for cervical cancer since 1940. Recently, a number of new technologies have been developed to improve the detection of cervical cancer and its precursors. However, there is substantial controversy about whether the new tests offer meaningful...

Jun 1, 2001 Issue
Evaluation and Management of the AGUS Papanicolaou Smear [Article]

Atypical glandular cells on Papanicolaou smears are an unusual but important cytologic diagnosis. The Bethesda system classifies atypical glandular cells of undetermined significance (AGUS) as glandular cells that demonstrate nuclear atypia appearing to exceed reactive or reparative changes but lack...

May 15, 1999 Issue
HPV Testing in the Evaluation of the Minimally Abnormal Papanicolaou Smear [Article]

Minor cytologic abnormalities of the cervix, such as atypical squamous cells of undetermined significance (ASCUS), are vastly more common than high-grade squamous intraepithelial lesions or invasive cancer. Current guidelines for the management of ASCUS include repeating the Papanicolaou (Pap) smear...

Pages: Previous 1 2 3 4

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now